06/17/2020

US Needs Drug Negotiating Power, ASCO Study Concludes

(The Center for Biosimilars) May 31, 2020 - Cancer drug prices are rising in the United States and Europe, but European regulators negotiate drug prices, and the results are seen in pricing trends, say investigators in a presentation at the American Society of Clinical Oncology. READ ARTICLE